|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Investments | |||||||
| Fixed maturity securities available-for-sale, at fair value (amortized cost: USD 789,619 – 2023, USD 538,311 – 2022, net of allowance for expected credit losses: USD 353 – December 31, 2023, USD 195 – December 31, 2022) | |||||||
| Equity securities, at fair value (cost: USD 24,056 – 2023, USD 31,906 – 2022) | |||||||
| Fixed maturity securities available-for-sale, at fair value (amortized cost: $1,054,347 – 2025, $1,023,866 – 2024, net of allowance for expected credit losses: $233 – 2025, $409 – 2024) | |||||||
| Equity securities, at fair value (cost: $16,086 – 2025, $25,334 – 2024) | |||||||
| Other investments, at fair value (cost: $12,028 – 2025, $12,500 – 2024) | |||||||
| Short-term investments | |||||||
| Term deposits | |||||||
| Equity-method investments measured at fair value | |||||||
| Fixed maturity securities held to maturity | |||||||
| Total investments | |||||||
| Cash and cash equivalents | |||||||
| Accrued investment income | |||||||
| Premiums receivable, net of allowance for expected credit losses ($13,595 – 2025, $12,756 – 2024) | |||||||
| Reinsurance recoverable, net of allowance for expected credit losses ($900 – 2025, $885 – 2024) | |||||||
| Ceded unearned premiums | |||||||
| Deferred policy acquisition costs, net of ceding commission | |||||||
| Deferred tax assets, net | |||||||
| Other assets | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
| LIABILITIES | |||||||
| Reserve for unpaid loss and loss adjustment expenses | |||||||
| Unearned premiums | |||||||
| Insurance and reinsurance payables | |||||||
| Other liabilities | |||||||
| Derivative financial liabilities | |||||||
| TOTAL LIABILITIES | |||||||
| SHAREHOLDERS’ EQUITY | |||||||
| Common shares (authorized: 750,000,000 shares at $0.01 par value per share; issued and outstanding: 42,842,216 shares – 2025, 45,108,936 shares – 2024) | |||||||
| Additional paid-in capital | |||||||
| Treasury shares, at cost (1,407 shares – 2025, 154,011 shares – 2024) | |||||||
| Accumulated other comprehensive income (loss), net of taxes | |||||||
| Retained earnings | |||||||
| TOTAL SHAREHOLDERS’ EQUITY | |||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
Loading...